Found 5 results

Name Type of Offering Accepted Date
Finch Therapeutics Group, Inc.
D 2018-03-05 14:48:04
Amount To Be Raised $36,399,996
Associated Brokers / Dealers N/A
CIK Number 0001733257
Filed Document 0001733257-18-000001
Exclusions or Exemptions 506c
Accepted Date 2018-03-05 14:48:04
Type of Offering D
Industry Biotechnology
Offering Tier N/A
Principal Place of Business MASSACHUSETTS
Revenue or Assets Decline to Disclose
Type of Security Equity
Finch Therapeutics Group, Inc.
D 2019-05-20 10:58:16
Amount To Be Raised $22,999,996
Associated Brokers / Dealers N/A
CIK Number 0001733257
Filed Document 0001733257-19-000001
Exclusions or Exemptions 506b
Accepted Date 2019-05-20 10:58:16
Type of Offering D
Industry Biotechnology
Offering Tier N/A
Principal Place of Business MASSACHUSETTS
Revenue or Assets Decline to Disclose
Type of Security Equity
Finch Therapeutics Group, Inc.
D 2020-09-17 15:54:04
Amount To Be Raised $90,000,000
Associated Brokers / Dealers N/A
CIK Number 0001733257
Filed Document 0001733257-20-000001
Exclusions or Exemptions 506b
Accepted Date 2020-09-17 15:54:04
Type of Offering D
Industry Biotechnology
Offering Tier N/A
Principal Place of Business MASSACHUSETTS
Revenue or Assets Decline to Disclose
Type of Security Equity
Finch Therapeutics Group, Inc.
D/A 2020-09-23 15:39:10
Amount To Be Raised $90,000,000
Associated Brokers / Dealers N/A
CIK Number 0001733257
Filed Document 0001733257-20-000002
Exclusions or Exemptions 506b
Accepted Date 2020-09-23 15:39:10
Type of Offering D/A
Industry Biotechnology
Offering Tier N/A
Principal Place of Business MASSACHUSETTS
Revenue or Assets Decline to Disclose
Type of Security Equity
Finch Therapeutics Group, Inc.
D/A 2019-07-19 11:08:27
Amount To Be Raised $53,465,316
Associated Brokers / Dealers N/A
CIK Number 0001733257
Filed Document 0001733257-19-000002
Exclusions or Exemptions 506b
Accepted Date 2019-07-19 11:08:27
Type of Offering D/A
Industry Biotechnology
Offering Tier N/A
Principal Place of Business MASSACHUSETTS
Revenue or Assets Decline to Disclose
Type of Security Equity